Ongoing clonal evolution in chronic myelomonocytic leukemia on hypomethylating agents: a computational perspective. [electronic resource]
- Leukemia 09 2018
- 2049-2054 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1476-5551
10.1038/s41375-018-0050-z doi
Biomarkers, Tumor Clonal Evolution--genetics DNA Methylation--drug effects Decitabine--pharmacology Genetic Heterogeneity Genome-Wide Association Study Humans Leukemia, Myelomonocytic, Chronic--drug therapy Models, Biological Polymorphism, Single Nucleotide Exome Sequencing